PharmaAI Helped Build a Personalized Cancer Vaccine. It Just Passed Phase 3
A personalized mRNA vaccine, designed with help from an algorithm, met its main goals in a Phase 3 melanoma trial run by Merck and Moderna.
Pharma · Company
Moderna
Covered since Most recent
Moderna, in collaboration with Merck, has developed a personalized mRNA cancer vaccine that successfully met its primary objectives in a Phase 3 trial for melanoma. The vaccine's design was aided by an algorithm, showcasing advancements in AI-assisted medical research.
0Stories
+0 in the last 30 days
0Deployments tracked
Latest: Aug 19, 2026
1,137patients enrolled
Latest tracker entry
Deployments
In the tracker →- intismeran autogene
pilot1,137 cancer therapy
Stories
1 storyPharma
